(Circulation. 1995;92:1710-1719.)
© 1995 American Heart Association, Inc.
Articles |
A Comparison of Quality of Life Scores in Patients With Angina Pectoris After Angioplasty Compared With After Medical Therapy
Outcomes of a Randomized Clinical Trial
Presented in part at the 41st Annual Meeting of the American College of Cardiology, Dallas, Tex, April 1992.
From the Research and Development Service, Department of Veterans Affairs Medical Center, West Roxbury (W.E.S., T.F., E.D.F., A.F.P.), Mass, and West Haven (P.H.), Conn.
Correspondence to William E. Strauss, MD, Cardiology Section (111A), Department of Veterans Affairs Medical Center, 1400 VFW Parkway, West Roxbury, MA 02132.
Background Evaluations of therapy for the treatment of angina have traditionally consisted of a combination of objective measures, such as exercise tolerance, and subjective markers, such as angina attack rate. Recently, the need to assess "how patients feel"—their quality of life (QOL)—has been regarded with increasing importance. Standard instruments are available to assess QOL and its change after therapeutic intervention. Although QOL instruments have been used to assess the efficacy of percutaneous transluminal coronary angioplasty (PTCA), they have not been used previously to compare the impact of PTCA with that of medical therapy in patients with angina pectoris. We report on the changes in self-assessed QOL among patients randomly assigned to treatment by PTCA or medical therapy and relate these measurements to changes in exercise performance and coronary angiograms.
Methods and Results Patients with stable angina, a positive exercise tolerance test, and at least 70% stenosis (index lesion) in the proximal two thirds of one major coronary artery were randomly assigned to receive PTCA or medical therapy. Six months after randomization, each patient underwent repeat exercise testing and coronary angiography. Before randomization and at the 6-month visit, patients completed a self-administered QOL questionnaire that measured physical functioning and psychological well-being. We compared the changes in QOL with changes between the baseline and 6-month exercise tests, stratified by terciles (decrease in duration, 0- to 2-minute increase, and >2-minute improvement). We also stratified patients by whether there was more or less than 2 SD change (18.8%) in diameter stenosis of the index lesion (initial minus follow-up angiogram), and we related these to changes in QOL measures. One hundred eighty-two patients with one-vessel disease completed baseline and 6-month questionnaires. At baseline, there were no differences in any QOL measurements between treatment groups. At the 6-month follow-up visit, there was greater improvement in both physical functioning and psychological well-being scores for patients receiving PTCA (+7.36±15.6, PTCA; +1.98±14.7, medical therapy; P<.02). Improvement in QOL variables was noted only in patients demonstrating an increase in exercise performance. Also, patients assigned to either treatment whose angiograms demonstrated more than 18.8% improvement in index lesion percent stenosis experienced a significant increase in their QOL scores.
Conclusions This was the first study of the relative changes in QOL measures assessed with the use of previously validated and standardized instruments in patients randomly assigned to treatment with PTCA or medical therapy. Patients assigned to PTCA demonstrated a significantly greater improvement in both physical and psychological measures. This improvement was noted in patients whose exercise performance improved and whose angiograms demonstrated an improvement in lesion severity.
Key Words: clinical trials • quality of life • angioplasty • angina
This article has been cited by other articles:
 |
|
 |
|
  J. A. Cairns Ranolazine: Augmenting the Antianginal Armamentarium J. Am. Coll. Cardiol., August 1, 2006; 48(3): 576 - 578. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kaul, B. L. Lytle, J. A. Spertus, E. R. DeLong, and E. D. Peterson Influence of Racial Disparities in Procedure Use on Functional Status Outcomes Among Patients With Coronary Artery Disease Circulation, March 15, 2005; 111(10): 1284 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Spertus, R. Nerella, R. Kettlekamp, J. House, S. Marso, A. M. Borkon, and J. S. Rumsfeld Risk of Restenosis and Health Status Outcomes for Patients Undergoing Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery Circulation, February 15, 2005; 111(6): 768 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Claude, C. Schindler, G. M. Kuster, M. Schwenkglenks, T. Szucs, P. Buser, S. Osswald, C. Kaiser, C. Gradel, W. Estlinbaum, et al. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease: Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME) Eur. Heart J., December 2, 2004; 25(24): 2195 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kaiser, G. M. Kuster, P. Erne, W. Amann, B. Naegeli, S. Osswald, P. Buser, H. Schlapfer, W. Brett, H.-R. Zerkowski, et al. Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina - on-treatment analysis of the TIME trial Eur. Heart J., June 2, 2004; 25(12): 1036 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Rumsfeld, D. J. Magid, M. E. Plomondon, J. Sacks, W. Henderson, M. Hlatky, G. Sethi, D. A. Morrison, and Veterans Affairs Angina With Extremely Serious Ope Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1732 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pfisterer, P. Buser, S. Osswald, U. Allemann, W. Amann, W. Angehrn, E. Eeckhout, P. Erne, W. Estlinbaum, G. Kuster, et al. Outcome of Elderly Patients With Chronic Symptomatic Coronary Artery Disease With an Invasive vs Optimized Medical Treatment Strategy: One-Year Results of the Randomized TIME Trial JAMA, March 5, 2003; 289(9): 1117 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Mark and M. A. Hlatky Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part II Circulation, July 30, 2002; 106(5): 626 - 630. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Rumsfeld Health Status and Clinical Practice: When Will They Meet? Circulation, July 2, 2002; 106(1): 5 - 7. [Full Text] [PDF]
|
|
|
|
|
|
R. Belardinelli, I. Paolini, G. Cianci, R. Piva, D. Georgiou, and A. Purcaro Exercise training intervention after coronary angioplasty: the ETICA trial J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1891 - 1900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O S Mortensen, J K Madsen, T Haghfelt, P Grande, K Saunamäki, S Haunsø, E Hjelms, H Arendrup, and t. D. study group Health related quality of life after conservative or invasive treatment of inducible postinfarction ischaemia Heart, November 1, 2000; 84(5): 535 - 540. [Abstract] [Full Text]
|
|
|
|
|
|
D. A. Taira, T. B. Seto, K. K. L. Ho, H. M. Krumholz, D. E. Cutlip, R. Berezin, R. E. Kuntz, and D. J. Cohen Impact of Smoking on Health-Related Quality of Life After Percutaneous Coronary Revascularization Circulation, September 19, 2000; 102(12): 1369 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pocock, R. A. Henderson, T. Clayton, G. H. Lyman, D. A. Chamberlain, and for the RITA-2 Trial Participants Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial J. Am. Coll. Cardiol., March 15, 2000; 35(4): 907 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kahler, M. Lutke, J. Weckmuller, R. Koster, T. Meinertz, and C.W. Hamm Coronary angioplasty in octogenarians. Quality of life and costs Eur. Heart J., December 2, 1999; 20(24): 1791 - 1798. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Harada, Y. Toki, Y. Numaguchi, H. Osanai, T. Ito, K. Okumura, and T. Hayakawa Prostacyclin synthase gene transfer inhibits neointimal formation in rat balloon-injured arteries without bleeding complications Cardiovasc Res, August 1, 1999; 43(2): 481 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rosanio, M. Tocchi, D. Cutler, B. F. Uretsky, G. A. Stouffer, C. R. deFilippi, E. J. MacInerney, S. R. Runge, J. Aaron, J. Otero, et al. Queuing for Coronary Angiography During Severe Supply-Demand Mismatch in a US Public Hospital: Analysis of a Waiting List Registry JAMA, July 14, 1999; 282(2): 145 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. DeYoung and D. A. Dichek Gene Therapy for Restenosis : Are We Ready? Circ. Res., February 23, 1998; 82(3): 306 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Versaci, A. Gaspardone, F. Tomai, F. Crea, L. Chiariello, and P. A. Gioffre A Comparison of Coronary-Artery Stenting with Angioplasty for Isolated Stenosis of the Proximal Left Anterior Descending Coronary Artery N. Engl. J. Med., March 20, 1997; 336(12): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 PTCA Beats Medical Therapy in Indices of Life Quality Journal Watch Cardiology, December 1, 1995; 1995(1201): 8 - 8. [Full Text]
|
|
|
|
 |
|
 Quality of Life after PTCA vs. Medical Therapy Journal Watch Psychiatry, December 1, 1995; 1995(1201): 17 - 17. [Full Text]
|
|
|
|
 |
|
 QUALITY OF LIFE AFTER PTCA VS. MEDICAL THERAPY Journal Watch (General), October 13, 1995; 1995(1013): 4 - 4. [Full Text]
|
|